Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01791738 · ClinicalTrials.gov registry record · Phase 1

Acetabular Shell Positioning Using Patient Specific Instruments

A Phase 1 study of Rheumatoid Arthritis and Avascular Necrosis, sponsored by The Cleveland Clinic.

Completed
Registry status
Phase 1
Development phase
36
Enrollment target
1
Study location

NCT01791738: Completed Phase 1 study of Rheumatoid Arthritis and Avascular Necrosis, sponsored by The Cleveland Clinic.

NCT01791738 is a Phase 1 study of Rheumatoid Arthritis and Avascular Necrosis that has completed, run by The Cleveland Clinic. The registered enrollment target is 36 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01791738, a Phase 1 study of Rheumatoid Arthritis and Avascular Necrosis, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
Phase 1
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The proposed study is a double-blinded randomized controlled trial comparing patient specific instruments with solely standardized instruments and pre-operative planning used for the placement of the acetabular cup prosthesis used in total hip arthroplasty. The investigators will enroll 36 patients who have consented to total hip arthroplasty for treatment of hip pathology. This treatment is a standard of care. Patients will receive standard of care pre- and post-operative care and placement of standard of care implants all of which are commercially available and FDA approved for general use for the clinical indications used in these patients. All patients will receive a pre-operative CT scan for surgical planning and comparison with post-operative CT scan. The difference in intervention between the groups will be the creation and use of patient specific instruments from the pre-operative planning session. These instruments will be used for placement of an indexing peripheral guide wire to direct acetabular preparation and placement of the shell assisting standard surgical instruments. Print-offs from the pre-operative plan will also be used in the treatment group. The post-operative scan will be performed within two weeks of the surgery for both the treatment and control groups. The investigators will analyze the difference in acetabular shell placement (acetabular version and abduction angle) from the pre-operatively planned CT scan. These differences will be compared between the control and experimental groups.

Interventions

  • PROCEDURE Acetabular positioning system

Study Locations (1)

Ohio

  • The Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2011-01
Est. Completion 2012-04
Phase Phase 1
The Cleveland Clinic

688 total trials

What the finished NCT01791738 record still lists

NCT01791738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Acetabular positioning system is the first listed.

NCT01791738 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01791738 about?

NCT01791738 is a clinical study titled "Acetabular Shell Positioning Using Patient Specific Instruments". The proposed study is a double-blinded randomized controlled trial comparing patient specific instruments with solely standardized instruments and pre-operative planning used for the placement of the acetabular cup prosthesis used in total hip arthroplasty. The investigators will enroll 36 patients...

What is the current status of trial NCT01791738?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2011-01. Estimated completion is 2012-04.

What conditions does trial NCT01791738 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Avascular Necrosis, Osteoarthritis, Hip.

What interventions are being tested in trial NCT01791738?

The interventions under investigation include: Acetabular positioning system (PROCEDURE).

Who is sponsoring clinical trial NCT01791738?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01791738 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01791738's enrollment target sits among peer trials

36 151st of 197 higher than 46 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01791738, the US trial registry maintained by the National Library of Medicine. NCT01791738 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.